BACKGROUND: Neuropsychological deficits constitute enduring trait-like features in bipolar disorder (BD), and persist in euthymia. White matter (WM) abnormalities are one of the most consistently reported findings in neuroimaging studies of BD. We hypothesized that neuropsychological performances could correlate with WM integrity in a sample of bipolar patients in core WM tracts. METHODS: Seventy-eight patients affected by BD were evaluated for verbal memory, working memory, psychomotor coordination, executive functions, attention and information processing, and verbal fluency through the Brief Assessment of Cognition in Schizophrenia. White matter integrity was evaluated using DTI and tract-based spatial statistics with threshold free cluster enhancement (p>0.949). RESULTS: We observed that cognitive performances in attention and information processing, working memory, executive functions and psychomotor coordination were associated with DTI measures of WM integrity in several association fibres: inferior and superior longitudinal fasciculus, inferior fronto-occipital fasciculus, cingulum bundle, corpus callosum, and corona radiata. LIMITATION: The drug treatments administered during the course of the illness could have influenced DTI measures and neurocognitive function. Other limitations include issues such as generalizability due to the lack of a control group, possible undetected past comorbidities, population stratification, and the presence of a 28% of patients which previously experienced delusions. CONCLUSIONS: This is the first study to use a validated cognitive battery to investigate the principal cognitive domains in BD. Our data confirm the importance of WM integrity as a neurobiological underpinning of cognitive deficits.
BACKGROUND: Neuropsychological deficits constitute enduring trait-like features in bipolar disorder (BD), and persist in euthymia. White matter (WM) abnormalities are one of the most consistently reported findings in neuroimaging studies of BD. We hypothesized that neuropsychological performances could correlate with WM integrity in a sample of bipolarpatients in core WM tracts. METHODS: Seventy-eight patients affected by BD were evaluated for verbal memory, working memory, psychomotor coordination, executive functions, attention and information processing, and verbal fluency through the Brief Assessment of Cognition in Schizophrenia. White matter integrity was evaluated using DTI and tract-based spatial statistics with threshold free cluster enhancement (p>0.949). RESULTS: We observed that cognitive performances in attention and information processing, working memory, executive functions and psychomotor coordination were associated with DTI measures of WM integrity in several association fibres: inferior and superior longitudinal fasciculus, inferior fronto-occipital fasciculus, cingulum bundle, corpus callosum, and corona radiata. LIMITATION: The drug treatments administered during the course of the illness could have influenced DTI measures and neurocognitive function. Other limitations include issues such as generalizability due to the lack of a control group, possible undetected past comorbidities, population stratification, and the presence of a 28% of patients which previously experienced delusions. CONCLUSIONS: This is the first study to use a validated cognitive battery to investigate the principal cognitive domains in BD. Our data confirm the importance of WM integrity as a neurobiological underpinning of cognitive deficits.
Authors: Aimee K Santucci; Lynn T Singer; Stephen R Wisniewski; James F Luther; Heather F Eng; Dorothy K Sit; Katherine L Wisner Journal: J Clin Psychiatry Date: 2017 Sep/Oct Impact factor: 4.384
Authors: Sheena I Dev; Tanya T Nguyen; Benjamin S McKenna; Ashley N Sutherland; Hauke Bartsch; Rebecca J Theilmann; Lisa T Eyler Journal: Am J Geriatr Psychiatry Date: 2017-02-16 Impact factor: 4.105
Authors: Saba Shahab; Benoit H Mulsant; Melissa L Levesque; Navona Calarco; Arash Nazeri; Anne L Wheeler; George Foussias; Tarek K Rajji; Aristotle N Voineskos Journal: Neuropsychopharmacology Date: 2018-12-20 Impact factor: 7.853
Authors: Elizabeth T Cox Lippard; Jennifer A Y Johnston; Linda Spencer; Susan Quatrano; Siyan Fan; Anjali Sankar; Judah Weathers; Brian Pittman; Maria A Oquendo; Hilary P Blumberg Journal: J Affect Disord Date: 2018-11-28 Impact factor: 4.839
Authors: Sara Poletti; Aye Mu Myint; Gregor Schüetze; Irene Bollettini; Elena Mazza; Doris Grillitsch; Clara Locatelli; Markus Schwarz; Cristina Colombo; Francesco Benedetti Journal: Eur Arch Psychiatry Clin Neurosci Date: 2016-09-12 Impact factor: 5.270
Authors: Lucija Abramovic; Marco P M Boks; Annabel Vreeker; Sanne Verkooijen; Annet H van Bergen; Roel A Ophoff; René S Kahn; Neeltje E M van Haren Journal: Eur Neuropsychopharmacol Date: 2018-05-18 Impact factor: 4.600
Authors: Guusje Collin; Martijn P van den Heuvel; Lucija Abramovic; Annabel Vreeker; Marcel A de Reus; Neeltje E M van Haren; Marco P M Boks; Roel A Ophoff; René S Kahn Journal: Hum Brain Mapp Date: 2015-10-10 Impact factor: 5.038
Authors: Susanne Meinert; Nico Nowack; Dominik Grotegerd; Jonathan Repple; Nils R Winter; Isabel Abheiden; Verena Enneking; Hannah Lemke; Lena Waltemate; Frederike Stein; Katharina Brosch; Simon Schmitt; Tina Meller; Julia-Katharina Pfarr; Kai Ringwald; Olaf Steinsträter; Marius Gruber; Igor Nenadić; Axel Krug; Elisabeth J Leehr; Tim Hahn; Katharina Thiel; Katharina Dohm; Alexandra Winter; Nils Opel; Ricarda I Schubotz; Tilo Kircher; Udo Dannlowski Journal: Mol Psychiatry Date: 2021-10-25 Impact factor: 13.437